Henry Schein (HSIC)
(Delayed Data from NSDQ)
$65.80 USD
-0.47 (-0.71%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $65.79 -0.01 (-0.02%) 7:10 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$65.80 USD
-0.47 (-0.71%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $65.79 -0.01 (-0.02%) 7:10 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Henry Schein Hurt by Higher Costs, Lacks Growth Drivers
by Zacks Equity Research
On Jan 10, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Henry Schein Named 2016's Best Animal Healthcare Provider
by Zacks Equity Research
Henry Schein, Inc. (HSIC) has been recognized as the "Best Animal Healthcare Product Provider 2016".
Henry Schein Buys Stake in Marrodent; Spurs Polish Foothold
by Zacks Equity Research
Henry Schein (HSIC) has recently completed its earlier announced purchase of 80% ownership of Marrodent.
Henry Schein's Q3 Results Impress, Pricing Pressure a Drag
by Zacks Equity Research
On Dec 6, we issued an updated research report on Melville, NY-based Henry Schein Inc. (HSIC).